Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted October 02, 2008
FDA Permits Incorrect Labeling on Generic Wellbutrin XL, But May Require Drug to be Tested
The FDA has acknowledged inconsistencies in the labeling of Budeprion XL, a generic version of the antidepressant Wellbutrin XL, according to an October 2, 2008 article from Dow Jones News service.
Join today to unlock all member benefits including full access to all recalls & warnings
Join NowAlready a member? Sign In Here.
Join now at www.consumerlab.com/join/